Bieerkehazhi et al. demonstrated that bosutinib has antiproliferative effects on NB cells, by reducing the activity of Src/Abl, PI3K/AKT/mTOR, MAPK/ERK, and JAK/STAT3 pathways. Here, PIK3CD is linked to neuroblastoma.